Literature DB >> 20089661

Novel function of CD81 in controlling hepatitis C virus replication.

Yong-Yuan Zhang1, Bai-Hua Zhang, Koji Ishii, T Jake Liang.   

Abstract

The mechanisms of hepatitis C virus (HCV) replication remain poorly understood, and the cellular factors required for HCV replication are yet to be completely defined. CD81 is known to mediate HCV entry. Our study uncovered an unexpected novel function of CD81 in the HCV life cycle that is important for HCV RNA replication. HCV replication occurred efficiently in infected cells with high levels of CD81 expression. In HCV-infected or RNA-transfected cells with low levels of CD81 expression, initial viral protein synthesis occurred normally, but efficient replication failed to proceed. The aborted replication could be restored by the transient transfection of a CD81 expression plasmid. CD81-dependent replication was demonstrated with both an HCV infectious cell culture and HCV replicon cells of genotypes 1b and 2a. We also showed that CD81 expression is positively correlated with the kinetics of HCV RNA synthesis but inversely related to the kinetics of viral protein production, suggesting that CD81 may control viral replication by directing viral RNA template function to RNA replication. Thus, CD81 may be necessary for the efficient replication of the HCV genome in addition to its role in viral entry.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20089661      PMCID: PMC2838140          DOI: 10.1128/JVI.02391-09

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  52 in total

Review 1.  Overview of hepatitis C virus genome structure, polyprotein processing, and protein properties.

Authors:  K E Reed; C M Rice
Journal:  Curr Top Microbiol Immunol       Date:  2000       Impact factor: 4.291

2.  Hepatocyte CD81 is required for Plasmodium falciparum and Plasmodium yoelii sporozoite infectivity.

Authors:  Olivier Silvie; Eric Rubinstein; Jean-François Franetich; Michel Prenant; Elodie Belnoue; Laurent Rénia; Laurent Hannoun; Wijnand Eling; Shoshana Levy; Claude Boucheix; Dominique Mazier
Journal:  Nat Med       Date:  2002-12-16       Impact factor: 53.440

Review 3.  Course and outcome of hepatitis C.

Authors:  Jay H Hoofnagle
Journal:  Hepatology       Date:  2002-11       Impact factor: 17.425

4.  Vitamin B12 and hepatitis C: molecular biology and human pathology.

Authors:  W B Lott; S S Takyar; J Tuppen; D H Crawford; M Harrison; T P Sloots; E J Gowans
Journal:  Proc Natl Acad Sci U S A       Date:  2001-04-10       Impact factor: 11.205

5.  Translating ribosomes inhibit poliovirus negative-strand RNA synthesis.

Authors:  D J Barton; B J Morasco; J B Flanegan
Journal:  J Virol       Date:  1999-12       Impact factor: 5.103

6.  Evaluation of prototype transmembrane 4 superfamily protein complexes and their relation to lipid rafts.

Authors:  C Claas; C S Stipp; M E Hemler
Journal:  J Biol Chem       Date:  2000-12-11       Impact factor: 5.157

7.  A genome-wide genetic screen for host factors required for hepatitis C virus propagation.

Authors:  Qisheng Li; Abraham L Brass; Aylwin Ng; Zongyi Hu; Ramnik J Xavier; T Jake Liang; Stephen J Elledge
Journal:  Proc Natl Acad Sci U S A       Date:  2009-08-27       Impact factor: 11.205

8.  Highly permissive cell lines for subgenomic and genomic hepatitis C virus RNA replication.

Authors:  Keril J Blight; Jane A McKeating; Charles M Rice
Journal:  J Virol       Date:  2002-12       Impact factor: 5.103

9.  Claudin-1 is a hepatitis C virus co-receptor required for a late step in entry.

Authors:  Matthew J Evans; Thomas von Hahn; Donna M Tscherne; Andrew J Syder; Maryline Panis; Benno Wölk; Theodora Hatziioannou; Jane A McKeating; Paul D Bieniasz; Charles M Rice
Journal:  Nature       Date:  2007-02-25       Impact factor: 49.962

10.  Infectious hepatitis C virus pseudo-particles containing functional E1-E2 envelope protein complexes.

Authors:  Birke Bartosch; Jean Dubuisson; François-Loïc Cosset
Journal:  J Exp Med       Date:  2003-03-03       Impact factor: 14.307

View more
  13 in total

1.  Identification of ligands that target the HCV-E2 binding site on CD81.

Authors:  Reem Al Olaby; Hassan M Azzazy; Rodney Harris; Brett Chromy; Jost Vielmetter; Rod Balhorn
Journal:  J Comput Aided Mol Des       Date:  2013-04-24       Impact factor: 3.686

2.  IQGAP2 is a novel interferon-alpha antiviral effector gene acting non-conventionally through the NF-κB pathway.

Authors:  Cynthia Brisac; Shadi Salloum; Victor Yang; Esperance A K Schaefer; Jacinta A Holmes; Stephane Chevaliez; Jian Hong; Charlie Carlton-Smith; Nadia Alatrakchi; Annie Kruger; Wenyu Lin; Raymond T Chung
Journal:  J Hepatol       Date:  2016-07-09       Impact factor: 25.083

3.  Dynamic Interaction of Stress Granules, DDX3X, and IKK-α Mediates Multiple Functions in Hepatitis C Virus Infection.

Authors:  Véronique Pène; Qisheng Li; Catherine Sodroski; Ching-Sheng Hsu; T Jake Liang
Journal:  J Virol       Date:  2015-03-04       Impact factor: 5.103

4.  Hepatitis C Virus Mimics Effects of Glypican-3 on CD81 and Promotes Development of Hepatocellular Carcinomas via Activation of Hippo Pathway in Hepatocytes.

Authors:  Yuhua Xue; Wendy M Mars; William Bowen; Aatur D Singhi; John Stoops; George K Michalopoulos
Journal:  Am J Pathol       Date:  2018-03-22       Impact factor: 4.307

5.  Determinants in the Ig Variable Domain of Human HAVCR1 (TIM-1) Are Required To Enhance Hepatitis C Virus Entry.

Authors:  Alla Kachko; Maria Isabel Costafreda; Iryna Zubkova; Jerome Jacques; Kazuyo Takeda; Frances Wells; Gerardo Kaplan; Marian E Major
Journal:  J Virol       Date:  2018-02-26       Impact factor: 5.103

6.  Different requirements for scavenger receptor class B type I in hepatitis C virus cell-free versus cell-to-cell transmission.

Authors:  Maria Teresa Catanese; Joana Loureiro; Christopher T Jones; Marcus Dorner; Thomas von Hahn; Charles M Rice
Journal:  J Virol       Date:  2013-05-22       Impact factor: 5.103

Review 7.  Roles of lipoprotein receptors in the entry of hepatitis C virus.

Authors:  Jingya Lyu; Hitomi Imachi; Kensaku Fukunaga; Takuo Yoshimoto; Huanxiang Zhang; Koji Murao
Journal:  World J Hepatol       Date:  2015-10-28

8.  Mathematical model of viral kinetics in vitro estimates the number of E2-CD81 complexes necessary for hepatitis C virus entry.

Authors:  Pranesh Padmanabhan; Narendra M Dixit
Journal:  PLoS Comput Biol       Date:  2011-12-08       Impact factor: 4.475

Review 9.  CD81 and hepatitis C virus (HCV) infection.

Authors:  Lucie Fénéant; Shoshana Levy; Laurence Cocquerel
Journal:  Viruses       Date:  2014-02-06       Impact factor: 5.048

Review 10.  CD81-receptor associations--impact for hepatitis C virus entry and antiviral therapies.

Authors:  Laetitia Zona; Rajiv G Tawar; Mirjam B Zeisel; Fei Xiao; Catherine Schuster; Joachim Lupberger; Thomas F Baumert
Journal:  Viruses       Date:  2014-02-18       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.